Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 22 items for :

  • "fibrinolysis" x
Clear All
Laura P B Elbers Department of Internal Medicine, Medical Center Slotervaart, Amsterdam, the Netherlands
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

Search for other papers by Laura P B Elbers in
Google Scholar
PubMed Close
,
Marije Wijnberge Department of Internal Medicine, Medical Center Slotervaart, Amsterdam, the Netherlands
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, the Netherlands

Search for other papers by Marije Wijnberge in
Google Scholar
PubMed Close
,
Joost C M Meijers Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
Department of Plasma Proteins, Sanquin Research, Amsterdam, the Netherlands

Search for other papers by Joost C M Meijers in
Google Scholar
PubMed Close
,
Dennis C W Poland Clinical Chemistry Laboratory, Medical Center Slotervaart, Amsterdam, the Netherlands

Search for other papers by Dennis C W Poland in
Google Scholar
PubMed Close
,
Dees P M Brandjes Department of Internal Medicine, Medical Center Slotervaart, Amsterdam, the Netherlands
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

Search for other papers by Dees P M Brandjes in
Google Scholar
PubMed Close
,
Eric Fliers Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

Search for other papers by Eric Fliers in
Google Scholar
PubMed Close
, and
Victor E A Gerdes Department of Internal Medicine, Medical Center Slotervaart, Amsterdam, the Netherlands
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

Search for other papers by Victor E A Gerdes in
Google Scholar
PubMed Close

Introduction An effect on markers of coagulation and fibrinolysis has been hypothesized for hyperparathyroidism as primary hyperparathyroidism is associated with an increased risk of cardiovascular (CV) morbidity and mortality ( 1 , 2 , 3

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0249
Volume/Issue:
Volume 7: Issue 2
Open access
Simon Chang Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Internal Medicine, Lillebaelt Hospital, Kolding, Denmark

Search for other papers by Simon Chang in
Google Scholar
PubMed Close
,
Arkadiusz J Goszczak NanoSYD, The Mads Clausen Institute, University of Southern Denmark, Sønderborg, Denmark

Search for other papers by Arkadiusz J Goszczak in
Google Scholar
PubMed Close
,
Anne Skakkebæk Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed Close
,
Jens Fedder Centre of Andrology and Fertility Clinic, Odense University Hospital, Odense, Denmark

Search for other papers by Jens Fedder in
Google Scholar
PubMed Close
,
Anders Bojesen Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Anders Bojesen in
Google Scholar
PubMed Close
,
M Vakur Bor Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark

Search for other papers by M Vakur Bor in
Google Scholar
PubMed Close
,
Moniek P M de Maat Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands

Search for other papers by Moniek P M de Maat in
Google Scholar
PubMed Close
,
Claus H Gravholt Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Claus H Gravholt in
Google Scholar
PubMed Close
, and
Anna-Marie B Münster Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark

Search for other papers by Anna-Marie B Münster in
Google Scholar
PubMed Close

decreased propensity for fibrinolysis has been previously proposed in KS VTE case series ( 1 , 10 , 11 ). Decreased fibrinolytic capacity is independently associated with an increased risk of VTE ( 12 , 13 ). Decreased fibrinolytic capacity has been

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-21-0490
Volume/Issue:
Volume 11: Issue 5
Open access
Malin Nylander Department of Obstetrics and Gynecology, Herlev Gentofte Hospital, Herlev, Denmark
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Malin Nylander in
Google Scholar
PubMed Close
,
Signe Frøssing Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark

Search for other papers by Signe Frøssing in
Google Scholar
PubMed Close
,
Caroline Kistorp Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark

Search for other papers by Caroline Kistorp in
Google Scholar
PubMed Close
,
Jens Faber Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Internal Medicine, Endocrine Unit, Herlev Gentofte Hospital, Herlev, Denmark

Search for other papers by Jens Faber in
Google Scholar
PubMed Close
, and
Sven O Skouby Department of Obstetrics and Gynecology, Herlev Gentofte Hospital, Herlev, Denmark
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Sven O Skouby in
Google Scholar
PubMed Close

Polycystic ovary syndrome (PCOS) is associated with increased risk of venous thromboembolism (VTE) and cardiovascular disease (CVD) in later life. We aimed to study the effect of liraglutide intervention on markers of VTE and CVD risk, in PCOS. In a double-blind, placebo-controlled, randomized trial, 72 overweight and/or insulin-resistant women with PCOS were randomized, in a 2:1 ratio, to liraglutide or placebo 1.8 mg/day. Endpoints included between-group difference in change (baseline to follow-up) in plasminogen activator inhibitor-1 levels and in thrombin generation test parameters: endogenous thrombin potential, peak thrombin concentration, lag time and time to peak. Mean weight loss was 5.2 kg (95% CI 3.0–7.5 kg, P < 0.001) in the liraglutide group compared with placebo. We detected no effect on endogenous thrombin potential in either group. In the liraglutide group, peak thrombin concentration decreased by 16.71 nmol/L (95% CI 2.32–31.11, P < 0.05) and lag time and time to peak increased by 0.13 min (95% CI 0.01–0.25, P < 0.05) and 0.38 min (95% CI 0.09–0.68, P < 0.05), respectively, but there were no between-group differences. There was a trend toward 12% (95% CI 0–23, P = 0.05) decreased plasminogen activator inhibitor-1 in the liraglutide group, and there was a trend toward 16% (95% CI −4 to 32, P = 0.10) reduction, compared with placebo. In overweight women with PCOS, liraglutide intervention caused an approximate 5% weight loss. In addition, liraglutide affected thrombin generation, although not significantly differently from placebo. A concomitant trend toward improved fibrinolysis indicates a possible reduction of the baseline thrombogenic potential. The findings point toward beneficial effects of liraglutide on markers of VTE and CVD risk, which should be further pursued in larger studies.

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0113
Volume/Issue:
Volume 6: Issue 2
Open access
Marc Blondon Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland

Search for other papers by Marc Blondon in
Google Scholar
PubMed Close
,
Emmanuel Biver Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland

Search for other papers by Emmanuel Biver in
Google Scholar
PubMed Close
,
Olivia Braillard Division of Primary Care Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland

Search for other papers by Olivia Braillard in
Google Scholar
PubMed Close
,
Marc Righini Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland

Search for other papers by Marc Righini in
Google Scholar
PubMed Close
,
Pierre Fontana Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland

Search for other papers by Pierre Fontana in
Google Scholar
PubMed Close
, and
Alessandro Casini Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland

Search for other papers by Alessandro Casini in
Google Scholar
PubMed Close

properties of the clot and its resistance to fibrinolysis, and appears altered in a variety of diseases of thrombotic or hemorrhagic phenotypes ( 16 , 17 ). We hypothesized that supplementation with vitamin D in deficient patients would be associated with

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0429
Volume/Issue:
Volume 8: Issue 11
Open access
Wang Chengji College of Physical Education, Chaohu University, Anhui Province, China

Search for other papers by Wang Chengji in
Google Scholar
PubMed Close
and
Fan Xianjin College of Physical Education, Chaohu University, Anhui Province, China

Search for other papers by Fan Xianjin in
Google Scholar
PubMed Close

hyperinsulinemia has been associated with impaired fibrinolysis ( 5 ). Diabetic patients have elevated levels of coagulation factors and impaired fibrinolysis, inducing a hypercoagulable state that may contribute to the increased risk of atherothrombotic events and

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0060
Volume/Issue:
Volume 7: Issue 4
Open access
Hong Wang Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Hong Wang in
Google Scholar
PubMed Close
,
Jie Cao Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Jie Cao in
Google Scholar
PubMed Close
,
Jian-bin Su Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Jian-bin Su in
Google Scholar
PubMed Close
,
Xue-qin Wang Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Xue-qin Wang in
Google Scholar
PubMed Close
,
Dong-mei Zhang Medical Research Center, Affiliated Hospital 2 of Nantong University, and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Dong-mei Zhang in
Google Scholar
PubMed Close
, and
Xiao-hua Wang Department of Endocrinology, Affiliated Hospital 2 of Nantong University and First People’s Hospital of Nantong City, Nantong, China

Search for other papers by Xiao-hua Wang in
Google Scholar
PubMed Close

contributes to many metabolic disorders, including hypercoagulation, hypo-fibrinolysis, dyslipidemia and hypertension ( 3 ). The hyperinsulinemic-euglycemic clamp technique is the gold standard for evaluating insulin resistance in humans but is costly for

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0087
Volume/Issue:
Volume 10: Issue 7
Open access
Agata Hanna Bryk-Wiązania Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Agata Hanna Bryk-Wiązania in
Google Scholar
PubMed Close
,
Mari Minasyan Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Mari Minasyan in
Google Scholar
PubMed Close
,
Alicja Hubalewska-Dydejczyk Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed Close
, and
Aleksandra Gilis-Januszewska Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed Close

platelets, increased thrombin generation, elevated concentrations of fibrinogen and fibrinolysis inhibitors, and compensatory elevation of endogenous anticoagulants such as protein C and protein S ( 3 , 4 , 5 , 6 ). However, no linear relationship with

Article Type:
Research Article
Collections:
Cardiovascular
DOI:
https://doi.org/10.1530/EC-23-0557
Volume/Issue:
Volume 13: Issue 9
Open access
M Cherenko Department of Medicine, Division of Endocrinology, Leiden University Medical Centre, Leiden, Netherlands

Search for other papers by M Cherenko in
Google Scholar
PubMed Close
,
N M Appelman-Dijkstra Department of Medicine, Division of Endocrinology, Leiden University Medical Centre, Leiden, Netherlands

Search for other papers by N M Appelman-Dijkstra in
Google Scholar
PubMed Close
,
A L Priego Zurita Department of Medicine, Division of Endocrinology, Leiden University Medical Centre, Leiden, Netherlands

Search for other papers by A L Priego Zurita in
Google Scholar
PubMed Close
,
N R Biermasz Department of Medicine, Division of Endocrinology, Leiden University Medical Centre, Leiden, Netherlands

Search for other papers by N R Biermasz in
Google Scholar
PubMed Close
,
O M Dekkers Department of Medicine, Division of Endocrinology, Leiden University Medical Centre, Leiden, Netherlands

Search for other papers by O M Dekkers in
Google Scholar
PubMed Close
,
,
F A Klok Department of Medicine, Division of Thrombosis and Haemostasis, Leiden University Medical Centre, Leiden, Netherlands

Search for other papers by F A Klok in
Google Scholar
PubMed Close
,
N Reisch Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany

Search for other papers by N Reisch in
Google Scholar
PubMed Close
,
A Aulinas Department of Endocrinology, Fundacio de Gestio Sanitaria Hospital de la Santa Creu i Sant Pau, IR-SantPau and CIBERER Unit 747 (ISCIII), Barcelona, Spain

Search for other papers by A Aulinas in
Google Scholar
PubMed Close
,
B Biagetti Department of Endocrinology, Hospital Universitari Vall d’Hebron, Barcelona, Spain

Search for other papers by B Biagetti in
Google Scholar
PubMed Close
,
S Cannavo Endocrine Unit, University Hospital AOU Policlinico G. Martino, Messina, Italy

Search for other papers by S Cannavo in
Google Scholar
PubMed Close
,
L Canu University Hospital Florence Careggi, Florence, Italy

Search for other papers by L Canu in
Google Scholar
PubMed Close
,
M Detomas Department of Internal Medicine, University Hospital Würzburg, Wuerzburg, Germany

Search for other papers by M Detomas in
Google Scholar
PubMed Close
,
F Devuyst Department of Endocrinology, Hôpital Universitaire de Bruxelles, Hôpital Erasme, Brussels, Belgium

Search for other papers by F Devuyst in
Google Scholar
PubMed Close
,
H Falhammar Department of Endocrinology, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Search for other papers by H Falhammar in
Google Scholar
PubMed Close
,
R A Feelders Department of Internal Medicine, Division of Endocrinology, Erasmus MC, Rotterdam, Netherlands

Search for other papers by R A Feelders in
Google Scholar
PubMed Close
,
F Ferrau Endocrine Unit, University Hospital AOU Policlinico G. Martino, Messina, Italy

Search for other papers by F Ferrau in
Google Scholar
PubMed Close
,
F Gatto IRCCS Ospedale Policlinico San Martino, Genova, Genoa, Italy

Search for other papers by F Gatto in
Google Scholar
PubMed Close
,
C Grasselli Cardiovascular Medicine Unit, AUSL-IRCCS, Reggio Emilia, Italy

Search for other papers by C Grasselli in
Google Scholar
PubMed Close
,
P van Houten Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, Netherlands

Search for other papers by P van Houten in
Google Scholar
PubMed Close
,
C Hoybye Department of Endocrinology, Karolinska University Hospital and Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Search for other papers by C Hoybye in
Google Scholar
PubMed Close
,
A M Isidori Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

Search for other papers by A M Isidori in
Google Scholar
PubMed Close
,
A Kyrilli Department of Endocrinology, Hôpital Universitaire de Bruxelles, Hôpital Erasme, Brussels, Belgium

Search for other papers by A Kyrilli in
Google Scholar
PubMed Close
,
P Loli Division of Endocrinology, San Raffaele Vita-Salute University, IRCCS San Raffaele Hospital Milan, Italy

Search for other papers by P Loli in
Google Scholar
PubMed Close
,
D Maiter Department of Endocrinology, Cliniques universitaires Saint-Luc – UCLouvain, Brussels, Belgium

Search for other papers by D Maiter in
Google Scholar
PubMed Close
,
E Nowak Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany

Search for other papers by E Nowak in
Google Scholar
PubMed Close
,
R Pivonello Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Università “Federico II” di Napoli, Naples, Italy

Search for other papers by R Pivonello in
Google Scholar
PubMed Close
,
O Ragnarsson Sahlgrenska Academy, Wallenberg Centre for Molecular and Translational Medicine, Institute of Medicine (O.R.), University of Gothenburg, Sweden

Search for other papers by O Ragnarsson in
Google Scholar
PubMed Close
,
R V Steenaard Department of Internal Medicine, Máxima MC, Veldhoven, Netherlands

Search for other papers by R V Steenaard in
Google Scholar
PubMed Close
,
N Unger University Hospital Essen, Department of Endocrinology, Diabetes and Metabolism, Essen, Germany

Search for other papers by N Unger in
Google Scholar
PubMed Close
,
A van de Ven Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, Netherlands

Search for other papers by A van de Ven in
Google Scholar
PubMed Close
,
S M Webb Department of Endocrinology, Fundacio de Gestio Sanitaria Hospital de la Santa Creu i Sant Pau, IR-SantPau and CIBERER Unit 747 (ISCIII), Barcelona, Spain

Search for other papers by S M Webb in
Google Scholar
PubMed Close
,
D Yeste Pediatric Endocrinology Service, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. CIBER Enfermedades Raras, Instituto Carlos III, Madrid, Spain

Search for other papers by D Yeste in
Google Scholar
PubMed Close
,
S F Ahmed Department of Medicine, Division of Endocrinology, Leiden University Medical Centre, Leiden, Netherlands
University of Glasgow, Office for Rare Conditions, Glasgow, UK
University of Glasgow, Developmental Endocrinology Research Group, Royal Hospital for Children, Glasgow, UK

Search for other papers by S F Ahmed in
Google Scholar
PubMed Close
, and
A M Pereira Department of Endocrinology & Metabolism, Amsterdam University Medical Centre, Amsterdam, Noord-Holland, Netherlands

Search for other papers by A M Pereira in
Google Scholar
PubMed Close

concentrations ( 11 , 12 ), impaired fibrinolysis ( 4 ) and endothelial dysfunction ( 13 ). Changes in pro- and anticoagulant factors may persist after successful surgery or medical therapy for at least several months ( 14 , 15 ). Given the lack of evidence

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-24-0046
Volume/Issue:
Volume 13: Issue 6
Open access
Katica Bajuk Studen Nuclear Medicine Department, University Medical Centre Ljubljana, Ljubljana, Slovenia

Search for other papers by Katica Bajuk Studen in
Google Scholar
PubMed Close
and
Marija Pfeifer Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Search for other papers by Marija Pfeifer in
Google Scholar
PubMed Close

preparation do not recommend these steps. Other/non-classical cardiovascular risk factors in PCOS PCOS is also associated with changes in circulating factors of coagulation and fibrinolysis, such as increased levels of factor VIIc, von

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-18-0129
Volume/Issue:
Volume 7: Issue 7
Open access
Charlotte Höybye Patient Area Endocrinology and Nephrology, Infection and Inflammation Theme, Karolinska University Hospital, Stockholm, Sweden
Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Search for other papers by Charlotte Höybye in
Google Scholar
PubMed Close
,
Laia Faseh Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Search for other papers by Laia Faseh in
Google Scholar
PubMed Close
,
Christos Himonakos Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
Department of Medicine, Karlstad Hospital, Karlstad, Sweden

Search for other papers by Christos Himonakos in
Google Scholar
PubMed Close
,
Tomasz Pielak NUTOPI Sp. z o. o., Poznan, Poland

Search for other papers by Tomasz Pielak in
Google Scholar
PubMed Close
, and
Jesper Eugen-Olsen Clinical Research Centre, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark

Search for other papers by Jesper Eugen-Olsen in
Google Scholar
PubMed Close

fibrinolysis ( 15 , 16 ). Binding of uPA to uPAR facilitates cleavage and generation of soluble uPAR (suPAR). suPAR positively correlates to the activation of the inflammatory and immune systems and is present in blood, urine and cerebrospinal fluid ( 15 , 16

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0159
Volume/Issue:
Volume 8: Issue 6
Open access